Losartan and diabetic nephropathy: commentaries on the RENAAL study

The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) study is a multinational, double-blind, randomized, placebo controlled trial...RENAAL研究（英文全称：Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan，即应用血管紧张素II拮抗剂（Angiotensin II Antagonist）氯沙坦（Losartan）降低非胰岛素依赖型糖尿病（Non-Insulin Dependent Diabetes Mellitus，简称NIDDM）患者终点事件的研究）是一项多国开展的双盲、随机安慰剂对照试验……